RXST Key Statistics, Chart & Performance
The current stock price of RXST is 12.03 USD. In the past month the price increased by 34.41%. In the past year, price decreased by -64.26%.
RXST Latest News, Press Relases and Analysis
RXST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| COO | COOPER COS INC/THE | 20.04 | 16.45B | ||
| SOLV | SOLVENTUM CORP | 13.74 | 14.15B | ||
| ALGN | ALIGN TECHNOLOGY INC | 16.31 | 11.31B | ||
| MMSI | MERIT MEDICAL SYSTEMS INC | 23.58 | 5.20B | ||
| LNTH | LANTHEUS HOLDINGS INC | 11.06 | 4.37B | ||
| HAE | HAEMONETICS CORP/MASS | 16.71 | 3.75B | ||
| ICUI | ICU MEDICAL INC | 18.23 | 3.58B | ||
| XRAY | DENTSPLY SIRONA INC | 7.09 | 2.24B | ||
| UFPT | UFP TECHNOLOGIES INC | 26.58 | 1.77B | ||
| NEOG | NEOGEN CORP | 24 | 1.56B | ||
| STAA | STAAR SURGICAL CO | N/A | 1.25B | ||
| EMBC | EMBECTA CORP | 3.96 | 687.49M |
Related stock screener links
About RXST
Company Profile
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Company Info
RXSIGHT INC
100 Columbia Street, Suite 120
Aliso Viejo CALIFORNIA US
CEO: Ron Kurtz
Employees: 498
Phone: 19495217822
RXSIGHT INC / RXST FAQ
What does RXSIGHT INC do?
RxSight, Inc. engages in the research, development, manufacture, and sale of light adjustable lenses and related capital equipment. The company is headquartered in Aliso Viejo, California and currently employs 498 full-time employees. The company went IPO on 2021-07-30. The firm's proprietary RxSight Light Adjustable Lens system (RxSight system) is commercially available premium cataract technology that enables doctors to customize and optimize visual acuity for patients after surgery. The RxSight system consists of its RxSight Light Adjustable Lens (LAL), the RxSight Light Delivery Device (LDD), and accessories. Its LAL is an intraocular lens (IOL) made of photosensitive material that changes shape in response to specific patterns of ultraviolet (UV) light generated by its LDD. In contrast, with the RxSight system, the surgeon implants the LAL during a standard cataract procedure, determines refractive error with patient input several weeks following surgery and then uses the LDD to modify the LAL with the precise visual correction needed to achieve the patient's desired vision outcomes.
Can you provide the latest stock price for RXSIGHT INC?
The current stock price of RXST is 12.03 USD. The price decreased by -2.27% in the last trading session.
Does RXST stock pay dividends?
RXST does not pay a dividend.
What is the ChartMill rating of RXSIGHT INC stock?
RXST has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the GICS sector and industry of RXST stock?
RXSIGHT INC (RXST) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the expected growth for RXST stock?
The Revenue of RXSIGHT INC (RXST) is expected to decline by -7.7% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.
What is RXSIGHT INC worth?
RXSIGHT INC (RXST) has a market capitalization of 494.67M USD. This makes RXST a Small Cap stock.
RXST Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to RXST. When comparing the yearly performance of all stocks, RXST is a bad performer in the overall market: 83.43% of all stocks are doing better.
RXST Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to RXST. The financial health of RXST is average, but there are quite some concerns on its profitability.
RXST Financial Highlights
Over the last trailing twelve months RXST reported a non-GAAP Earnings per Share(EPS) of -0.88. The EPS decreased by -6.02% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -11.58% | ||
| ROE | -12.95% | ||
| Debt/Equity | 0 |
RXST Forecast & Estimates
16 analysts have analysed RXST and the average price target is 9.97 USD. This implies a price decrease of -17.1% is expected in the next year compared to the current price of 12.03.
For the next year, analysts expect an EPS growth of -51.22% and a revenue growth -7.7% for RXST